Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
12.79
+0.33 (2.65%)
Dec 20, 2024, 4:00 PM EST - Market closed
DAWN Employees
Day One Biopharmaceuticals had 155 employees as of December 31, 2023. The number of employees increased by 34 or 28.10% compared to the previous year.
Employees
155
Change (1Y)
34
Growth (1Y)
28.10%
Revenue / Employee
$657,761
Profits / Employee
-$543,826
Market Cap
1.29B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 155 | 34 | 28.10% |
| Dec 31, 2022 | 121 | 66 | 120.00% |
| Dec 31, 2021 | 55 | 35 | 175.00% |
| Dec 31, 2020 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evolent Health | 4,700 |
| STAAR Surgical Company | 1,057 |
| MiMedx Group | 895 |
| Alphatec Holdings | 839 |
| Intellia Therapeutics | 526 |
| Arvinas | 445 |
| Harrow | 315 |
| Aurinia Pharmaceuticals | 300 |
DAWN News
- 4 days ago - Day One to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development - GlobeNewsWire
- 4 weeks ago - Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Day One Biopharmaceuticals, Inc. (DAWN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Day One Reports Third Quarter 2024 Financial Results and Corporate Progress - GlobeNewsWire
- 2 months ago - Day One to Report Third Quarter 2024 Financial Results Wednesday, October 30, 2024 - GlobeNewsWire
- 5 months ago - Day One Reports Second Quarter 2024 Financial Results and Corporate Progress - GlobeNewsWire
- 5 months ago - Day One Announces Oversubscribed $175.0 Million Private Placement - GlobeNewsWire